Answer
Comirnaty LP.8.1 30 micrograms/dose is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals aged 12 years and older, in accordance with official recommendations.
Sources for this answer
- Comirnaty LP.8.1 30 microgram/dose dispersion for injection in pre-filled syringeBioNTech - Pfizer · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated
Sources checked